Pathology of CAG repeat diseases

被引:57
|
作者
Yamada, M
Tsuji, S
Takahashi, H
机构
[1] Niigata Univ, Inst Brain Res, Dept Pathol, Niigata 9518585, Japan
[2] Niigata Univ, Inst Brain Res, Dept Neurol, Niigata 9518585, Japan
关键词
CAG repeat disease; dentatorubral-pallidoluysian atrophy; Huntington's disease; Machado-Joseph disease; neuronal intranuclear inclusion; transcription factor;
D O I
10.1046/j.1440-1789.2000.00354.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuronal intranuclear inclusions have become the neuropathological signature of the CAG repeat diseases, although their cytotoxicity is a matter of controversy. It has been demonstrated that the inclusions in dentatorubral-pallidoluysian atrophy (DRPLA) and Machado-Joseph disease (MJD) were immunopositive for several transcription factors such as TATA-binding protein (TBP), TBP-associated factor (TAF(II)130), Sp1, cAMP-responsive element-binding protein (CREB) and CREB-binding protein, suggesting that neuronal degeneration in polyglutamine diseases may result from nuclear depletion of transcription factors containing the glutamine-rich domain. It was also revealed that, in the DRPLA brain, expanded polyglutamine stretches were diffusely accumulated in neuronal nucleoplasm. This nuclear pathology involved many neurons in various nervous system regions, such as the cerebral cortex, thalamus, substantia nigra, pontine nuclei, reticular formation and inferior olive, in addition to the previously recognized affected regions. The diffuse nuclear labeling was also detected in MJD, Huntington's disease, and spinal and bulbar muscular atrophy, suggesting that this nuclear pathology may be a characteristic feature and may exert certain influence on certain nuclear functions of many neurons in the CAG repeat diseases.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 50 条
  • [1] Molecular pathology of CAG repeat diseases
    Nukina, N
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S49 - S49
  • [2] Clinical aspects of CAG repeat diseases
    Nance, MA
    BRAIN PATHOLOGY, 1997, 7 (03) : 881 - 900
  • [3] Involvement of lysosomes in the pathogenesis of CAG repeat diseases
    Yamada, M
    Tsuji, S
    Takahashi, H
    ANNALS OF NEUROLOGY, 2002, 52 (04) : 498 - 503
  • [4] DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
    Zhang, Nan
    Bewick, Brittani
    Schultz, Jason
    Tiwari, Anjana
    Krencik, Robert
    Zhang, Aijun
    Adachi, Kaho
    Xia, Guangbin
    Yun, Kyuson
    Sarkar, Partha
    Ashizawa, Tetsuo
    NEUROTHERAPEUTICS, 2021, 18 (03) : 1710 - 1728
  • [5] DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
    Nan Zhang
    Brittani Bewick
    Jason Schultz
    Anjana Tiwari
    Robert Krencik
    Aijun Zhang
    Kaho Adachi
    Guangbin Xia
    Kyuson Yun
    Partha Sarkar
    Tetsuo Ashizawa
    Neurotherapeutics, 2021, 18 : 1710 - 1728
  • [6] The central role of DNA damage and repair in CAG repeat diseases
    Massey, Thomas H.
    Jones, Lesley
    DISEASE MODELS & MECHANISMS, 2018, 11 (01)
  • [7] Genotype-phenotype correlation in CAG-repeat diseases
    Yamada, M
    Tsuji, S
    Takahashi, H
    NEUROPATHOLOGY, 2002, 22 (04) : 317 - 322
  • [8] The repeat expansion detection method in the analysis of diseases with CAG/CTG repeat expansion: Usefulness and limitations
    Martorell, L
    Pujana, MA
    Volpini, V
    Sanchez, A
    Joven, J
    Vilella, E
    Estivill, X
    HUMAN MUTATION, 1997, 10 (06) : 486 - 488
  • [9] CAG repeat number governs the development rate of pathology in Huntington's disease
    Penney, JB
    Vonsattel, JP
    MacDonald, ME
    Gusella, JF
    Myers, RH
    ANNALS OF NEUROLOGY, 1997, 41 (05) : 689 - 692
  • [10] The neuropathology of CAG repeat diseases: Review and update of genetic and molecular features
    Robitaille, Y
    LopesCendes, I
    Becher, M
    Rouleau, G
    Clark, AW
    BRAIN PATHOLOGY, 1997, 7 (03) : 901 - 926